JP Morgan says higher-ROCE EMS firms may deserve premium valuations
In short
JP Morgan said EMS companies with the same earnings growth can still get different valuations if one uses capital better. The report says higher ROCE can lead to better returns on the money invested.
This matters for investors looking at EMS stocks. The reporting does not name which companies could benefit or give any price targets.
What the reporting says
JP Morgan said EMS companies with similar earnings growth but higher ROCE can generate better returns on deployed capital, according to a report cited by BusinessLine. The note did not name specific firms or disclose valuation targets in the available reporting. The immediate takeaway is that investors may favor capital-efficient EMS names, but the coverage does not state any forecast or recommendation beyond that broad view.
Why it matters
JP Morgan’s report, as summarized by BusinessLine, focuses on EMS firms and says higher ROCE can support premium valuations when earnings growth is similar. The available reporting does not identify specific companies, target prices, or a timing trigger. For investors, the message is that capital efficiency may matter as much as growth when judging EMS names.